Skip to main page content
U.S. flag

An official website of the United States government

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

1973
2025

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1973 1
1975 1
1977 2
1979 2
1980 1
1981 3
1982 1
1983 2
1984 4
1985 3
1986 3
1987 10
1988 8
1989 6
1990 8
1991 8
1992 18
1993 16
1994 5
1995 12
1996 21
1997 18
1998 12
1999 16
2000 14
2001 6
2002 12
2003 23
2004 17
2005 16
2006 24
2007 19
2008 19
2009 19
2010 14
2011 26
2012 21
2013 19
2014 18
2015 29
2016 20
2017 24
2018 13
2019 9
2020 25
2021 26
2022 36
2023 21
2024 14
2025 1

Publication date

Text availability

Article attribute

Article type

Additional filters

Search Results

624 results

Results by year

Filters applied: . Clear all
Page 1
Expert consensus document: Clinical and molecular diagnosis, screening and management of Beckwith-Wiedemann syndrome: an international consensus statement.
Brioude F, Kalish JM, Mussa A, Foster AC, Bliek J, Ferrero GB, Boonen SE, Cole T, Baker R, Bertoletti M, Cocchi G, Coze C, De Pellegrin M, Hussain K, Ibrahim A, Kilby MD, Krajewska-Walasek M, Kratz CP, Ladusans EJ, Lapunzina P, Le Bouc Y, Maas SM, Macdonald F, Õunap K, Peruzzi L, Rossignol S, Russo S, Shipster C, Skórka A, Tatton-Brown K, Tenorio J, Tortora C, Grønskov K, Netchine I, Hennekam RC, Prawitt D, Tümer Z, Eggermann T, Mackay DJG, Riccio A, Maher ER. Brioude F, et al. Nat Rev Endocrinol. 2018 Apr;14(4):229-249. doi: 10.1038/nrendo.2017.166. Epub 2018 Jan 29. Nat Rev Endocrinol. 2018. PMID: 29377879 Free PMC article. Review.
Although the consensus group recommends a tumour surveillance programme targeted by molecular subgroups, surveillance might differ according to the local health-care system (for example, in the United States), and the results of targeted and universal surveillance should b …
Although the consensus group recommends a tumour surveillance programme targeted by molecular subgroups, surveillance might differ according …
Podocytopathies.
Kopp JB, Anders HJ, Susztak K, Podestà MA, Remuzzi G, Hildebrandt F, Romagnani P. Kopp JB, et al. Nat Rev Dis Primers. 2020 Aug 13;6(1):68. doi: 10.1038/s41572-020-0196-7. Nat Rev Dis Primers. 2020. PMID: 32792490 Free PMC article. Review.
Podocytopathies are kidney diseases in which direct or indirect podocyte injury drives proteinuria or nephrotic syndrome. ...In addition to genetic variants, environmental triggers such as immune-related, infection-related, toxic and haemodynamic factors and obesity are al …
Podocytopathies are kidney diseases in which direct or indirect podocyte injury drives proteinuria or nephrotic syndrome. ...In addit …
Autophagy in kidney homeostasis and disease.
Tang C, Livingston MJ, Liu Z, Dong Z. Tang C, et al. Nat Rev Nephrol. 2020 Sep;16(9):489-508. doi: 10.1038/s41581-020-0309-2. Epub 2020 Jul 23. Nat Rev Nephrol. 2020. PMID: 32704047 Free PMC article. Review.
Dysregulated autophagy contributes to the pathogenesis of acute kidney injury, to incomplete kidney repair after acute kidney injury and to chronic kidney disease of varied aetiologies, including diabetic kidney disease, focal segmental g …
Dysregulated autophagy contributes to the pathogenesis of acute kidney injury, to incomplete kidney repair after acute kidn
Podocyte injury and its consequences.
Nagata M. Nagata M. Kidney Int. 2016 Jun;89(6):1221-30. doi: 10.1016/j.kint.2016.01.012. Epub 2016 Mar 19. Kidney Int. 2016. PMID: 27165817 Free article. Review.
Recent podocyte biology and gene disruption studies in vivo indicate a causal relationship between abnormalities of single podocyte molecules and proteinuria and glomerulosclerosis. Podocytes live under various stresses and pathological stimuli. ...
Recent podocyte biology and gene disruption studies in vivo indicate a causal relationship between abnormalities of single podocyte m …
Hypertension: physiology and pathophysiology.
Hall JE, Granger JP, do Carmo JM, da Silva AA, Dubinion J, George E, Hamza S, Speed J, Hall ME. Hall JE, et al. Compr Physiol. 2012 Oct;2(4):2393-442. doi: 10.1002/cphy.c110058. Compr Physiol. 2012. PMID: 23720252 Review.
Short-term and long-term BP regulation involve the integrated actions of multiple cardiovascular, renal, neural, endocrine, and local tissue control systems. Clinical and experimental observations strongly support a central role for the kidneys in the long-term regu …
Short-term and long-term BP regulation involve the integrated actions of multiple cardiovascular, renal, neural, endocrine, and local
Cilia and polycystic kidney disease.
Ma M. Ma M. Semin Cell Dev Biol. 2021 Feb;110:139-148. doi: 10.1016/j.semcdb.2020.05.003. Epub 2020 May 28. Semin Cell Dev Biol. 2021. PMID: 32475690 Review.
Polycystic kidney disease (PKD), comprising autosomal dominant polycystic kidney disease (ADPKD) and autosomal recessive polycystic kidney disease (ARPKD), is characterized by incessant cyst formation in the kidney and liver. ...PC1/2 are multi-pass tr …
Polycystic kidney disease (PKD), comprising autosomal dominant polycystic kidney disease (ADPKD) and autosomal recessive polyc …
Polycystic kidney disease.
Harris PC, Torres VE. Harris PC, et al. Annu Rev Med. 2009;60:321-37. doi: 10.1146/annurev.med.60.101707.125712. Annu Rev Med. 2009. PMID: 18947299 Free PMC article. Review.
The PKD1 protein, polycystin-1, is a large receptor-like protein, whereas polycystin-2 is a transient receptor potential channel. The polycystin complex localizes to primary cilia and may act as a mechanosensor essential for maintaining the differentiated state of epitheli …
The PKD1 protein, polycystin-1, is a large receptor-like protein, whereas polycystin-2 is a transient receptor potential channel. The polycy …
Overview of complement activation and regulation.
Noris M, Remuzzi G. Noris M, et al. Semin Nephrol. 2013 Nov;33(6):479-92. doi: 10.1016/j.semnephrol.2013.08.001. Semin Nephrol. 2013. PMID: 24161035 Free PMC article. Review.
When complement is hyperactivated, as occurs in autoimmune diseases or in subjects with dysfunctional regulatory proteins, it drives a severe inflammatory response in numerous organs. The kidney appears to be particularly vulnerable to complement-mediated inflammatory inju …
When complement is hyperactivated, as occurs in autoimmune diseases or in subjects with dysfunctional regulatory proteins, it drives a sever …
Polycystic kidney disease: novel insights into polycystin function.
Luo L, Roy S, Li L, Ma M. Luo L, et al. Trends Mol Med. 2023 Apr;29(4):268-281. doi: 10.1016/j.molmed.2023.01.005. Epub 2023 Feb 15. Trends Mol Med. 2023. PMID: 36805211 Review.
Autosomal dominant polycystic kidney disease (ADPKD) is a life-threatening monogenic disease caused by mutations in PKD1 and PKD2 that encode polycystin 1 (PC1) and polycystin 2 (PC2). PC1/2 localize to cilia of renal epithelial cells, and their function is believed …
Autosomal dominant polycystic kidney disease (ADPKD) is a life-threatening monogenic disease caused by mutations in PKD1 and PKD2 tha …
Molecules Great and Small: The Complement System.
Mathern DR, Heeger PS. Mathern DR, et al. Clin J Am Soc Nephrol. 2015 Sep 4;10(9):1636-50. doi: 10.2215/CJN.06230614. Epub 2015 Jan 7. Clin J Am Soc Nephrol. 2015. PMID: 25568220 Free PMC article. Review.
Inherited and/or acquired abnormalities of complement regulators, which requisitely limit restraint on alternative pathway complement activation, contribute to the pathogenesis of the C3 nephropathies and atypical hemolytic uremic syndrome. Increasing evidence links comple …
Inherited and/or acquired abnormalities of complement regulators, which requisitely limit restraint on alternative pathway complement …
624 results